Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya Cui

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Drug Design, Development and Therapy|August 27, 2013
Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature reviewHai-Fei Chen, Li-Ping Xu, Zhi-Yong Luo, et al.
American Journal of Cancer Research|March 9, 2022
Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatmentYun-Ju Ma, Hai-Ping Dai, Qing-Ya Cui, et al.
Nature Biomedical Engineering|June 16, 2026
Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancerFurong Huang, Fuwen Yuan, Kexin Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 14, 2020
Association of the Polymorphism rs13259960 in SLEAR With Predisposition to Systemic Lupus ErythematosusZhen Fan, Xiaowei Chen, Lu Liu, et al.
Hepatobiliary Surgery and Nutrition|August 25, 2021
Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimenXu-Ya Cui, Xue-Chuan Li, Jiu-Jie Cui, et al.
Cancer Medicine|September 14, 2023
Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancerZi-Yao Jia, Yi-Di Zhu, Xiang-Song Wu, et al.
The Journal of Clinical Investigation|June 2, 2025
TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementiaFrederick J Arnold, Ya Cui, Sebastian Michels, et al.
Blood Cancer Journal|October 28, 2025
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trialSheng-Li Xue, Mei-Jing Liu, Chong-Sheng Qian, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Drug Design, Development and Therapy|August 27, 2013
Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature reviewHai-Fei Chen, Li-Ping Xu, Zhi-Yong Luo, et al.
American Journal of Cancer Research|March 9, 2022
Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatmentYun-Ju Ma, Hai-Ping Dai, Qing-Ya Cui, et al.
Nature Biomedical Engineering|June 16, 2026
Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancerFurong Huang, Fuwen Yuan, Kexin Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 14, 2020
Association of the Polymorphism rs13259960 in SLEAR With Predisposition to Systemic Lupus ErythematosusZhen Fan, Xiaowei Chen, Lu Liu, et al.
Hepatobiliary Surgery and Nutrition|August 25, 2021
Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimenXu-Ya Cui, Xue-Chuan Li, Jiu-Jie Cui, et al.
Cancer Medicine|September 14, 2023
Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancerZi-Yao Jia, Yi-Di Zhu, Xiang-Song Wu, et al.
The Journal of Clinical Investigation|June 2, 2025
TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementiaFrederick J Arnold, Ya Cui, Sebastian Michels, et al.
Blood Cancer Journal|October 28, 2025
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trialSheng-Li Xue, Mei-Jing Liu, Chong-Sheng Qian, et al.
Pageof 11